Catalyst Wire Dossier Catalyst Wire Dossier

Bexotegrast

PLN-74809 · Pliant Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bexotegrast, covering 2026-08-05 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]

See pricing